Lexicon Pharmaceuticals Inc (LXRX)

NASDAQ
2.365
+0.035(+1.50%)
  • Volume:
    279,500
  • Day's Range:
    2.345 - 2.440
  • 52 wk Range:
    1.310 - 6.330

LXRX Overview

Prev. Close
2.33
Day's Range
2.345-2.44
Revenue
300K
Open
2.36
52 wk Range
1.31-6.33
EPS
-0.652
Volume
279,500
Market Cap
458.32M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,676,024
P/E Ratio
-4.03
Beta
1.43
1-Year Change
-52.83%
Shares Outstanding
193,793,551
Next Earnings Date
Nov 03, 2022
What is your sentiment on Lexicon?
or
Vote to see community's results!

Lexicon Pharmaceuticals Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Lexicon Pharmaceuticals Inc Analysis

Lexicon Pharmaceuticals Inc Company Profile

Lexicon Pharmaceuticals Inc Company Profile

Employees
87

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its pipeline includes Sotagliflozin, LX9211, and LX2761. Sotagliflozin is an orally-delivered small molecule compound that is being developed for the treatment of heart failure and type I diabetes, and type II diabetes, heart failure and chronic kidney disease. LX9211 is an orally-delivered small molecule compound that is being developed for the treatment of neuropathic pain. The Company is conducting a Phase II clinical trial of LX9211 in diabetic peripheral neuropathic pain and a second Phase II clinical trial of LX9211 in post-herpetic neuralgia. LX2761 is an orally-delivered small molecule compound that is designed to inhibit sodium-glucose cotransporter 1 (SGLT1) locally in the gastrointestinal tract without any inhibition of sodium-glucose cotransporter 2 (SGLT2) in the kidney.

Read More

Analyst Price Target

Average20.000 (+749.26% Upside)
High20
Low20
Price2.355
No. of Analysts1
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellBuyStrong SellStrong Sell
SummaryStrong SellStrong SellNeutralStrong SellStrong Sell
  • (:shopping is coming again lower then 2
    1
    • buy time guys
      1
      • Institutionals more than 80 percents of shares. Meaning short term share value does not show the real potential.
        1
        • What the heck was that?
          1
          • Just an estimate
            0
            • Soon 9
              0
              • Buy buy buy
                0
                • Double digits by the end of the month this is a good play that’s flying under the radar. I keep adding every week everything in the $6’s is an easy three bagger
                  0
                  • what are you waiting for guys this will end the year 12-14$ easy regardiren
                    0
                    • 14$ eoy facts
                      0
                      • 12,5
                        0